The mechanism of liver dysfunction in endogenous septic shock model mice
The mechanism of liver dysfunction in endogenous septic shock model mice
批准号:
15590402
负责人:
OHNO Naohito
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
脓毒症是一种全身性炎症综合征,通常由细菌感染引起,并与多器官功能衰竭和功能障碍有关。尽管有有效的抗生素,感染性休克的死亡率仍然很高。我们通过反复给药吲哚美辛(IND)和β-葡聚糖(BG)建立了小鼠脓毒症的动物模型。BG和IND联合用药可致大鼠严重死亡,使各脏器白细胞数量增加,白细胞活化1。BG/IND处理小鼠的肝脏用缓冲福尔马林固定,苏木精-伊红染色。脓毒症小鼠肝脏非实质细胞率升高。BG/IND小鼠各脏器细菌数量明显高于对照小鼠。此外,BG/IND给药小鼠血清中TNF-α、MCP-1和IL-6浓度升高。提示BG/ ind给药后,胃肠道严重损伤和通透性增加,导致溃疡、多脏器炎症和脓毒症。给予BG/IND的小鼠从腹腔渗出细胞(PEC)培养中产生显著浓度的一氧化氮(NO)。为观察NO对大鼠致死性的影响,采用NOS抑制剂L-NAME。L-NAME增加死亡率。L-NAME和BG/IND处理可显著提高PEC中IL-1β、IL-6和TNF-α的产生。在L-NAME和BG/IND联合治疗的小鼠中,GOT和GPT的释放也增加。提示在该模型中NO的产生具有保护作用。抗生素治疗的BG/IND小鼠存活时间延长。此外,LPS诱导的炎症细胞因子的产生在抗生素处理的小鼠血清中减少。这些事实强烈表明,抗生素治疗可以保护小鼠免受LPS的致敏,从而降低败血症的风险,如肠道微生物易位和白细胞积聚。
英文摘要
Sepsis is a systemic inflammatory syndrome commonly caused by bacterial infection and is associated with multiple organ failure and dysfunction. Despite effective antibiotics, septic shock remains the high mortality. We have developed an animal model of sepsis in mice by repeatedly administering two drugs, indomethacin (IND) and β-glucan (BG). The combination of BG and IND induced severe lethality and increased the number of leukocytes in various organs and these cells were activated.1. The livers of BG/IND treated mice were fixed in buffered formalin and stained with hematoxylin-eosin. The rate of nonparenchymal cell was increased in the livers of septic mice. BG/IND mice contained significantly higher numbers of bacteria than control mice in various organs. Moreover, TNF-α,MCP-1, and IL-6 concentrations of BG/IND administered mice in sera were enhanced. It suggested that severe damage and increased permeability of the gastrointestinal tract led to ulcers, inflammation of multiple organs and sepsis on administration of BG/IND.2. The mice administered BG/IND produced a significant concentration of nitric oxide (NO) from peritoneal exuded cells (PEC) culture. To examine the effect of NO on the lethality, a NOS inhibitor, L-NAME was administered. L-NAME increased the mortality. Treatment with L-NAME and BG/IND enhanced production of IL-1β,IL-6 and TNF-α in PEC was significantly increased. The release of GOT and GPT was also increased in mice treated with the combination of L-NAME and BG/IND. It suggested that the production of NO has a protective effect in this model.3. BG/IND administered mice treated with antibiotics prolonged the survival. Moreover, LPS elicited productions of inflammatory cytokines were decreased in sera of mice treated with antibiotics. These facts strongly suggested that the antibiotics treatment protected mice from the sensitization to LPS and thus reduced risk of sepsis, such as microbial translocation and leukocyte accumulation in the gut.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Particulate and soluble β-glucans from Candida albicans modulate cytokine release from human leukocytes
来自白色念珠菌的颗粒状和可溶性 β-葡聚糖调节人类白细胞的细胞因子释放
DOI:
--
发表时间:
2005
期刊:
Toxicology of 1→3-Beta-Glucans
影响因子:
--
作者:
[Ken-ichi Ishibashi, Yukari Nakagawa, Naohito Ohno, Toshimi Murai]
通讯作者:
Toshimi Murai
Structure and immunomodulating activity of fungal β-1,3-glucan
真菌β-1,3-葡聚糖的结构和免疫调节活性
DOI:
--
发表时间:
2005
期刊:
Dojin News 114
影响因子:
--
作者:
[Sachiko Nameda, Maki Saito, Noriko N.Miura, Yoshiyuki Adachi, Naohito Ohno, Naohito Ohno]
通讯作者:
Naohito Ohno
Fate of β-glucans in vivo : organ distribution and degradation mechanisms of fungal β-glucans in the body
β-葡聚糖在体内的命运:真菌β-葡聚糖在体内的器官分布和降解机制
DOI:
--
发表时间:
2005
期刊:
Toxicology of 1→3-Beta-Glucans
影响因子:
--
作者:
[Sachiko Nameda, Maki Saito, Noriko N.Miura, Yoshiyuki Adachi, Naohito Ohno, Naohito Ohno, Yoshiyuki Adachi, Noriko N.Miura]
通讯作者:
Noriko N.Miura
Effect of nitric oxide on β-glucan/indomethacin-induced septic shock
一氧化氮对β-葡聚糖/吲哚美辛诱导的感染性休克的影响
DOI:
--
发表时间:
2005
期刊:
Biol. Pharm. Bull 28
影响因子:
--
作者:
[Sachiko Nameda, Maki Saito, Noriko N.Miura, Yoshiyuki Adachi, Naohito Ohno]
通讯作者:
Naohito Ohno
β-glucan receptor (s) and their signal transduction
β-葡聚糖受体及其信号转导
DOI:
--
发表时间:
2005
期刊:
Toxicology of 1→3-Beta-Glucans
影响因子:
--
作者:
[Sachiko Nameda, Maki Saito, Noriko N.Miura, Yoshiyuki Adachi, Naohito Ohno, Naohito Ohno, Yoshiyuki Adachi]
通讯作者:
Yoshiyuki Adachi
共 8 条
Characterization of immunotoxicological and immunopathological roles of fungal PAMPs
-
批准号:22590406
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:OHNO Naohito
-
依托单位:
Lethal Toxicity of NSAID in BRM Primed Mice
-
批准号:10672059
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1998
-
负责人:OHNO Naohito
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型无源生物电场膜器械与NsAIDs类药物静脉给药对于单髁关节置换术后严重疼痛治疗的优效性研究
-
批准号:2026JJ82286
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张彦
-
依托单位:
NSAIDs与硫化氢联合通过激活JNK通路及调控ROS水平诱导胃癌细胞凋亡的机制研究
-
批准号:2026JJ81993
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖政
-
依托单位:
负载 NSAIDs 的纳米马达微针系统用于类风湿
关节炎的抗炎镇痛作用和机制研究
-
批准号:TGY24H090026
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:方韬
-
依托单位:
灭酸类NSAIDs在饮用水氯消毒过程中的降解机理和转化产物的毒性评价研究
-
批准号:82003423
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马利云
-
依托单位:
NSAIDs非经典途径在急性胰腺炎相关自噬调控中的作用
-
批准号:81970557
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:潘阳林
-
依托单位:
基于Nrf2/ARE信号通路探讨大型溞在NSAIDs暴露下的氧化应激响应及其种群变化
-
批准号:31770554
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2017
-
负责人:聂湘平
-
依托单位:
高良姜对NSAIDs引起大鼠溃疡性胃损伤的保护作用及内在机理研究
-
批准号:81560721
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2015
-
负责人:张俊清
-
依托单位:
NSAIDs调控ASIC1与ASIC3影响食管酸敏感性的机制研究
-
批准号:81170344
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:邹多武
-
依托单位:
NSAIDs增强卵巢癌细胞对顺铂、紫杉醇药物敏感性的机理研究
-
批准号:30772305
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:杨红
-
依托单位:
NSAIDs肿瘤预防作用的非COX-2依赖性途径研究
-
批准号:30300410
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:吴静
-
依托单位: